News

Clínic Barcelona

Research March 31 2022

Controlling the dose of a liver transplant rejection drug reduces the risk of developing cancer

A multi-centre study, in which the Clínic-IDIBAPS participated, identified, in nearly 2,500 transplant patients, the main risk factors for the develo1

Clínic Barcelona

Research January 28 2022

Prophylactic transfusions of blood products do not prevent bleeding following endoscopic treatment of oesophageal varices in patients with cirrhosis

This analysis, the largest conducted to date and led by Hospital Clínic–IDIBAPS researchers, provides evidence of the inefficacy of this therapeutic1

Clínic Barcelona

Research April 8 2021

Factors related to improvement are established in patients with alcoholic liver cirrhosis on a transplant waiting list

A study led by researchers from the Clínic-IDIBAPS and the CIBEREHD and published in the Journal of Hepatology shows that up to 9% of patients with a1